Relmada Therapeutics, Inc.

Direct answer

Relmada Therapeutics, Inc. is publicly traded on NASDAQ under the ticker RLMD.

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology firm, concentrating its efforts on developing various therapeutic solutions for ailments affecting the central nervous system (CNS) and other disorders. The company's primary drug candidate is Esmethadone (also known as d-methadone, dextromethadone, or REL-1017), a novel chemical compound. This N-methyl-D-aspartate receptor antagonist is currently...

Can you invest in Relmada Therapeutics, Inc.?

Yes. Relmada Therapeutics, Inc. trades publicly on NASDAQ as RLMD.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Relmada Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.